EUVIMEDOpdag EUVIMED
Netzwerk-MetaanalyseSystematische ÜbersichtOpen access · CC BY 4.0

Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis

Yi Xu iD, Yimin Shen iD, Delong Chen iD, Pengfei Zhao iD, Jun Jiang iD

Journal of Interventional Cardiology · 2021-05-05 · 2021 · 1-12

DOI: 10.1155/2021/9934535 ↗

At a glance

Netzwerk-Metaanalyse in Journal of Interventional Cardiology, published on 2021-05-05. Written by Yi Xu and 4 co-authors. Institution: Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009, China. Major MEDLINE topics: Coronary Restenosis, Drug Therapy, Combination, Drug-Eluting Stents, Percutaneous Coronary Intervention. Cited 5 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

This network meta-analysis aimed to evaluate the efficacy and safety of different dual antiplatelet therapies (DAPTs) after percutaneous coronary intervention (PCI) with drug-eluting stents (DESs).

Methods

Randomized controlled trials (RCTs) comparing longer-term (>12 months) DAPT (L-DAPT), 12-month DAPT (DAPT 12Mo), 6-month DAPT (DAPT 6Mo), 3-month DAPT followed by aspirin monotherapy (DAPT 3Mo + ASA), 3-month DAPT followed by a P2Y12 receptor inhibitor monotherapy (DAPT 3Mo + P2Y12), or 1-month DAPT with a P2Y12 receptor inhibitor monotherapy (DAPT 1Mo + P2Y12) were searched. Primary endpoints were all-cause mortality, cardiac death, myocardial infarction (MI), major bleeding, any bleeding, definite or probable stent thrombosis (ST), and net adverse clinical events (NACE). This Bayesian network meta-analysis was performed with the random-effects model.

Results

Twenty-four RCTs (n = 81339) were included. In comparison with L-DAPT, DAPT 6Mo (OR: 0.50, 95% CI: 0.29–0.83), DAPT 3Mo + P2Y12 (OR: 0.38, 95% CI: 0.18–0.82), DAPT 3Mo + ASA (OR: 0.44, 95% CI: 0.17–0.98), and DAPT 1Mo + P2Y12 (OR: 0.45, 95% CI: 0.14–0.93) were associated with a lower risk of major bleeding. DAPT 3Mo + P2Y12 (OR: 0.58, 95% CI: 0.38–0.88) reduced the risk of any bleeding when compared with DAPT 12Mo. L-DAPT decreased the risk of MI and definite or probable stent ST when compared with DAPT 6Mo. DAPT 3Mo + P2Y12 decreased the risk of NACE in comparison with DAPT 6Mo and DAPT 12Mo. No significant difference in all-cause mortality and cardiac death was observed. In patients with acute coronary syndrome, DAPT 6Mo was comparable to DAPT 12Mo.

Conclusion

Short-term (1–3 months) DAPT is noninferior to DAPT 6Mo after DESs implantation, while L-DAPT reduces MI and definite or probable ST rates. DAPT 3Mo + P2Y12 might be a reasonable trade-off in patients with high risk of bleeding accompanied by ischemia.

Subjects

MeSH terms (MEDLINE)

Coronary RestenosisDrug Therapy, CombinationDrug-Eluting StentsPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsHumansHemorrhageRisk Adjustment

Substances

Platelet Aggregation Inhibitors

Authors and institutions

  • Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang 310009, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.

ORCID profiles: Yi Xu, Yimin Shen, Delong Chen, Pengfei Zhao, Jun Jiang

Cite

APA

Xu, Y., Shen, Y., Chen, D., Zhao, P., & Jiang, J. (2021). Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis. Journal of Interventional Cardiology, 2021, 1-12. https://doi.org/10.1155/2021/9934535

Vancouver

Xu Y, Shen Y, Chen D, Zhao P, Jiang J. Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis. Journal of Interventional Cardiology. 2021;2021:1-12. doi:10.1155/2021/9934535

BibTeX
@article{Xu2021,
  author = {Xu, Yi and Shen, Yimin and Chen, Delong and Zhao, Pengfei and Jiang, Jun},
  title = {Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis},
  journal = {Journal of Interventional Cardiology},
  year = {2021},
  volume = {2021},
  pages = {1--12},
  doi = {10.1155/2021/9934535}
}
Start for free →